IOL CHEMICALS & PHARM. | TTK HEALTHCARE | IOL CHEMICALS & PHARM./ TTK HEALTHCARE |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.7 | 34.5 | 39.6% | View Chart |
P/BV | x | 1.6 | 2.4 | 66.1% | View Chart |
Dividend Yield | % | 1.0 | 0.6 | 159.0% |
IOL CHEMICALS & PHARM. TTK HEALTHCARE |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
TTK HEALTHCARE Mar-23 |
IOL CHEMICALS & PHARM./ TTK HEALTHCARE |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 1,106 | 48.5% | |
Low | Rs | 272 | 668 | 40.8% | |
Sales per share (Unadj.) | Rs | 377.6 | 513.2 | 73.6% | |
Earnings per share (Unadj.) | Rs | 23.7 | 31.6 | 75.0% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 40.7 | 77.6% | |
Dividends per share (Unadj.) | Rs | 4.00 | 10.00 | 40.0% | |
Avg Dividend yield | % | 1.0 | 1.1 | 87.7% | |
Book value per share (Unadj.) | Rs | 256.8 | 674.7 | 38.1% | |
Shares outstanding (eoy) | m | 58.71 | 14.13 | 415.5% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 1.7 | 62.0% | |
Avg P/E ratio | x | 17.1 | 28.0 | 60.8% | |
P/CF ratio (eoy) | x | 12.8 | 21.8 | 58.8% | |
Price / Book Value ratio | x | 1.6 | 1.3 | 119.8% | |
Dividend payout | % | 16.9 | 31.6 | 53.3% | |
Avg Mkt Cap | Rs m | 23,743 | 12,529 | 189.5% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 1,234 | 136.3% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 7,251 | 305.8% | |
Other income | Rs m | 256 | 483 | 53.0% | |
Total revenues | Rs m | 22,427 | 7,734 | 290.0% | |
Gross profit | Rs m | 2,257 | 313 | 719.9% | |
Depreciation | Rs m | 462 | 128 | 360.5% | |
Interest | Rs m | 165 | 52 | 314.4% | |
Profit before tax | Rs m | 1,887 | 616 | 306.1% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 170 | 291.8% | |
Profit after tax | Rs m | 1,391 | 447 | 311.5% | |
Gross profit margin | % | 10.2 | 4.3 | 235.4% | |
Effective tax rate | % | 26.2 | 27.5 | 95.3% | |
Net profit margin | % | 6.3 | 6.2 | 101.9% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 10,664 | 90.6% | |
Current liabilities | Rs m | 5,025 | 2,108 | 238.4% | |
Net working cap to sales | % | 20.9 | 118.0 | 17.7% | |
Current ratio | x | 1.9 | 5.1 | 38.0% | |
Inventory Days | Days | 43 | 13 | 338.8% | |
Debtors Days | Days | 8 | 464 | 1.8% | |
Net fixed assets | Rs m | 11,017 | 994 | 1,108.9% | |
Share capital | Rs m | 587 | 141 | 415.5% | |
"Free" reserves | Rs m | 14,490 | 9,393 | 154.3% | |
Net worth | Rs m | 15,077 | 9,534 | 158.1% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 11,658 | 177.4% | |
Interest coverage | x | 12.5 | 12.8 | 97.6% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 0.6 | 172.3% | |
Return on assets | % | 7.5 | 4.3 | 175.7% | |
Return on equity | % | 9.2 | 4.7 | 197.0% | |
Return on capital | % | 13.6 | 7.0 | 194.0% | |
Exports to sales | % | 26.7 | 9.1 | 295.2% | |
Imports to sales | % | 0 | 1.4 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 657 | 902.7% | |
Imports (cif) | Rs m | NA | 102 | 0.0% | |
Fx inflow | Rs m | 5,930 | 657 | 902.7% | |
Fx outflow | Rs m | 6,052 | 163 | 3,718.2% | |
Net fx | Rs m | -122 | 494 | -24.6% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | -261 | -468.9% | |
From Investments | Rs m | -1,200 | 330 | -364.1% | |
From Financial Activity | Rs m | -41 | -124 | 33.1% | |
Net Cashflow | Rs m | -18 | -55 | 33.2% |
Indian Promoters | % | 48.2 | 74.6 | 64.6% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 3.0 | 56.9% | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 25.4 | 203.7% | |
Shareholders | 130,003 | 17,221 | 754.9% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA ZYDUS LIFESCIENCES DR. REDDYS LAB
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | TTK HEALTHCARE | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.11% | -0.57% | 0.45% |
1-Month | 5.76% | 7.86% | 2.55% |
1-Year | -2.63% | 25.81% | 56.14% |
3-Year CAGR | -12.88% | 32.65% | 15.22% |
5-Year CAGR | 16.82% | 18.45% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the TTK HEALTHCARE share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of TTK HEALTHCARE the stake stands at 74.6%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of TTK HEALTHCARE.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
TTK HEALTHCARE paid Rs 10.0, and its dividend payout ratio stood at 31.6%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of TTK HEALTHCARE.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.